Publications database

During the year 2021 new roadmaps were defined for the agency’s Strategy 2025 and for its accompanying document, the Reitox Development Framework (RDF). These two roadmaps describe the activities and milestones to be implemented to reach the strategic and specific objectives set out in the longer-...

The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025. At the heart of the agency’s work in 2021 will be the development of a new business model, which places customers and digital...

This is the first Programming Document fully grounded in the EMCDDA Strategy 2025 and it sets a milestone in the strategic and operational planning framework of the EMCDDA. Among the highlights for this period will be a follow up on the outcome of the fourth external evaluation of the EMCDDA. An...

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by collecting, analysing, interpreting and disseminating data at national level, as well as by...

This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better informed drug policy and action. Adopted unanimously by the agency’s key stakeholders in 2016, the strategy is the result of a year-...

The EMCDDA strategy and work programme for 2016–18 and the 2016 annual work programme is based on the EMCDDA’s vision to contribute to a more secure and a healthier Europe. A more proactive approach, combined with a greater emphasis to knowledge transfer, strategic analysis and threat assessment...

The 2014 Work programme continues to implement the commitments set out in the EMCDDA’s 2013–15 strategy and work programme. It builds on the achievements made in 2013 where measures were put in place to ensure that the EMCDDA’s approach remains appropriate to the challenge of reporting on an...

The EMCDDA treatment strategy provides a coherent strategic framework for data collection on treatment responses to drug use in Europe. Resulting from cross-unit collaboration in 2010–12, it offers a common conceptual framework which brings together reporting mechanisms and tools developed in...

The 2013–15 strategy and work programme is the third one since the EMCDDA’s recast Regulation in 2006. It is built around three top-level commitments: (a) providing a relevant, timely and responsive analysis of the drug situation; (b) efficiency: deriving maximum value from activities and...